W007 Hands-on: Lasers
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session is geared toward all levels of dermatologists, from beginner and intermediate to advanced levels. It offers small groups, hands-on experience practicing a variety of laser skills and techniques. Approaches to patient assessment and selection, treatment planning, equipment selection, laser safety, and proper application of devices will be covered. Small groups will rotate between stations demonstrating ablative resurfacing, nonablative rejuvenation, tattoo and pigment removal, acne and vascular lesions, skin tightening, fat melting, and body contouring. Participants will complete a pre- and post-assessment of procedural skills covered in this session.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Discuss current indications and treatment protocols for laser and light treatments including vascular, tattoo, pigment, nonablative, fractional, and ablative lasers.
Identify appropriate patients and gain treatment pearls for skin tightening, fat melting, and body contouring procedures.
SCHEDULE
5:00 PM
Hands-on Lasers
SPEAKERS
Michael Abrouk, MD
Saud Aleissa, MD, FAAD
Mathew M Avram, MD, JD
Ashish Bhatia, MD, FAAD
Jeremy A. Brauer, MD, FAAD
Rishi Chopra, MS, MD, FAAD
Catherine M DiGiorgio, MS, MD, FAAD
David Hashemi, MD, MBA, FAAD
Jamie Hu, MD, FAAD
H. Ray Jalian, MD, FAAD
Ryan C. Kelm, MD
Yakir S Levin, MD, PhD, FAAD
Ardalan Minokadeh, MD, PhD, FAAD
Morgan BriAnne Murphrey, MD, MS, FAAD
Oge C Onwudiwe, MD, FAAD
David M Ozog, MD, FAAD
Jill S. Waibel, MD, FAAD
Mara C Weinstein Velez, MD, FAAD
Douglas Wu, MD, PhD, FAAD
Adam Wulkan, MD, FAAD
SPEAKER DISCLOSURES
Michael Abrouk, MD
AbbVie – Investigator(Salary); Croma-Pharma GmbH Austria – Investigator(Fees); Cytrellis Biosystems, Inc – Investigator(Grants/Research Funding); Evolus, Inc. – Investigator(Grants/Research Funding); Galderma – Investigator(Fees); Hydrafacial – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Fees);
Saud Aleissa, MD, FAAD
No financial relationships exist with ineligible companies.
Mathew M Avram, MD, JD
Allergan, Inc – Consultant (1099 relationship)(Fees); Cytrellis Biosystems, Inc – Consultant(Stock), Consultant(Stock Options); La Jolla NanoMedical – Consultant (1099 relationship)(Stock Options); Masters of Aesthetics, Inc. – Founder(Fees); Sofwave – Consultant (1099 relationship)(Stock Options);
Ashish Bhatia, MD, FAAD
AbbVie – Other(Grants/Research Funding), Stockholder Public Company(Stock Options); Alastin Skincare, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding); Bausch Health – Consultant (1099 relationship)(Fees), Stockholder Public Company(Stock); BioMarck Pharmaceuticals, Ltd. – Advisory Board(No Compensation Received), Board of Directors(Honoraria), Stockholder(No Compensation Received); Bristol-Myers Squibb – Advisory Board(Honoraria); Caliway Biopharmaceuticals Co., Ltd – Advisory Board(No Compensation Received); Carpe – Consultant (1099 relationship)(Fees), Stockholder Private Company(Stock Options); Cutera, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Other(Grants/Research Funding), Speaker(Honoraria), Stockholder(Stock); Cynosure-Lutronic – Advisory Board(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Stockholder Public Company(No Compensation Received); Derm Education Foundation – Advisory Board(Honoraria), Speaker(Honoraria); Derm.md, Inc. – Board of Directors(No Compensation Received), Stockholder(No Compensation Received); Eli Lilly – Other(Grants/Research Funding); Elsevier Inc. – Consultant(Honoraria); Emblation, Ltd. – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding); Evolus, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); GenZum Life Sciences – Stockholder(No Compensation Received); Glo-Pharma, Inc. – Consultant (1099 relationship)(Fees); La Mer – Advisory Board(Honoraria); Medline Industries, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Other(Grants/Research Funding), Speaker(Honoraria); MiMedx Group, Inc – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Novascan – Other(Grants/Research Funding); Obagi Medical – Consultant (1099 relationship)(Fees); Obagi Medical Products – Consultant (1099 relationship)(Fees); Ortho Dermatologics – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); OurSelf – Board of Directors(No Compensation Received); Ourself – Consultant (1099 relationship)(Fees); Paradigm Medical Communications, LLC – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pulse Biosciences – Other(Grants/Research Funding); R2 Technologies – Other(Grants/Research Funding); RBC Consultants – Consultant (1099 relationship)(Fees); Revance Therapeutics, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sentient Lasers – Speaker(Fees); SimSkin – Stockholder(No Compensation Received); SofWave – Consultant (1099 relationship)(Fees); Sol Science – Other(No Compensation Received); Solta Medical – Advisory Board(Honoraria), Consultant(Honoraria); Sonoma Pharmaceuticals – Stockholder Public Company(No Compensation Received); Strata Skin Sciences – Advisory Board(Honoraria), Stockholder Public Company(Stock Options); Theravant Corporation – Advisory Board(Honoraria), Board of Directors(No Compensation Received), Speaker(Honoraria), Stockholder(No Compensation Received); Zalea, LLC – Stockholder Private Company(No Compensation Received);
Jeremy A. Brauer, MD, FAAD
Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Cartessa Aesthetics – Investigator(Grants/Research Funding); Solta Medical – Consultant(Honoraria);
Rishi Chopra, MS, MD, FAAD
Accure, Inc – Consultant(Fees); Cutera, Inc. – Speaker(Honoraria); Cynosure – Consultant (1099 relationship)(Equipment); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Evolus, Inc. – Speaker(Honoraria); Sofwave – Speaker(Honoraria);
Catherine M DiGiorgio, MS, MD, FAAD
Acclaro Medical – Other(Equipment); Quthero, Inc – Advisory Board(Stock Options), Investigator(Honoraria); Revelle Aesthetics, Inc. – Consultant(No Compensation Received);
David Hashemi, MD, MBA, FAAD
No financial relationships exist with ineligible companies.
Jamie Hu, MD, FAAD
No financial relationships exist with ineligible companies.
H. Ray Jalian, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Accure Medical, LLC – Stockholder(Stock); Bausch & Lomb (HK) Ltd. – Speaker(Fees); Candesant Biomedical, Inc. – Advisory Board(Fees); Cytrellis Biosystems, Inc – Advisory Board(Fees); Galderma – Investigator(Fees); Zeltiq Aesthetics – Consultant(Fees);
Ryan C. Kelm, MD
No financial relationships exist with ineligible companies.
Yakir S Levin, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Ardalan Minokadeh, MD, PhD, FAAD
Allergan Aesthetics – Investigator(Grants/Research Funding); Evolus, Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Galderma – Investigator(Grants/Research Funding); Merz Aesthetics – Consultant (1099 relationship)(Honoraria), Speaker/Faculty Education(Honoraria); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); symatese – Investigator(Grants/Research Funding);
Morgan BriAnne Murphrey, MD, MS, FAAD
No financial relationships exist with ineligible companies.
Oge C Onwudiwe, MD, FAAD
No financial relationships exist with ineligible companies.
David M Ozog, MD, FAAD
Biofrontera AG – Investigator(Grants/Research Funding); Cutera – Investigator(Equipment); Galderma USA – Investigator(Grants/Research Funding); Michelson Diagnostics – Investigator(Grants/Research Funding); miRagen Therapeutics, Inc. – Investigator(Grants/Research Funding); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sciton, Inc. – Investigator(Equipment);
Jill S. Waibel, MD, FAAD
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);
Mara C Weinstein Velez, MD, FAAD
Alastin Skincare, Inc – Advisory Board(Honoraria); Galderma Research & Development, LLC – Advisory Board(Honoraria);
Douglas Wu, MD, PhD, FAAD
Allergan, Inc. – Speaker/Faculty Education(Honoraria); Galderma USA – Speaker/Faculty Education(Honoraria); Syneron Candela – Consultant(Honoraria);
Adam Wulkan, MD, FAAD
No financial relationships exist with ineligible companies.